Explore more publications!
Mauritius Healthcare Daily
Got News to Share?

Mauritius Healthcare Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Mauritius Healthcare Daily.

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

Press releases published on January 27, 2026

PreatLoc™ by Preat® is Now Available
Jan. 27, 2026

PreatLoc™ by Preat® is Now Available

Indeterminate GlobeNewswire
Canix Acquires Major Competitor Trym To Create Industry-Leading ERP Management For Cannabis Industry
Jan. 27, 2026

Canix Acquires Major Competitor Trym To Create Industry-Leading ERP Management For Cannabis Industry

Indeterminate GlobeNewswire
Global Pharmaceutical Manufacturing Software Market to Reach USD 5.52 Billion by 2030 | MarketsandMarkets™
Jan. 27, 2026

Global Pharmaceutical Manufacturing Software Market to Reach USD 5.52 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
Halo Pharma to become a stand-alone Drug Product Contract Development and Manufacturing Organization (CDMO)
Jan. 27, 2026

Halo Pharma to become a stand-alone Drug Product Contract Development and Manufacturing Organization (CDMO)

Indeterminate GlobeNewswire
INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives
Jan. 27, 2026

INmune Bio Inc Issues Shareholder Letter Reviewing 2025 Milestones and Outlining 2026 Strategic Initiatives

Indeterminate GlobeNewswire
Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026
Jan. 27, 2026

Evosep Launches IQ/OQ Protocols for the Evosep Eno System at WCBP 2026

Indeterminate GlobeNewswire
Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation
Jan. 27, 2026

Truveta launches real-time clinical trials solution to accelerate study design, enrollment, and evidence generation

Indeterminate GlobeNewswire
Organizations Join Forces to Map How Human Muscle Regenerates
Jan. 27, 2026

Organizations Join Forces to Map How Human Muscle Regenerates

Indeterminate GlobeNewswire
Bicycle Health Appoints Rick Dean as Chief Executive Officer to Lead Next Phase of Growth
Jan. 27, 2026

Bicycle Health Appoints Rick Dean as Chief Executive Officer to Lead Next Phase of Growth

Indeterminate GlobeNewswire
Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe
Jan. 27, 2026

Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe

Indeterminate GlobeNewswire
Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned
Jan. 27, 2026

Next-Generation Tablo Hemodialysis System Receives FDA Clearance, Second Quarter Launch Planned

Indeterminate GlobeNewswire
Imprivata Pledges Support for CMS “Kill the Clipboard” Initiative to Simplify and Secure Patient Access to Medical Records
Jan. 27, 2026

Imprivata Pledges Support for CMS “Kill the Clipboard” Initiative to Simplify and Secure Patient Access to Medical Records

Indeterminate GlobeNewswire
Global Clinical Mass Spectrometry Market to Reach USD 3.31 Billion by 2031 | MarketsandMarkets™
Jan. 27, 2026

Global Clinical Mass Spectrometry Market to Reach USD 3.31 Billion by 2031 | MarketsandMarkets™

Indeterminate GlobeNewswire
Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data
Jan. 27, 2026

Myriad Advances MRD Commercialization Timeline, Bolstered by New Study Data

Indeterminate GlobeNewswire
Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations
Jan. 27, 2026

Propanc Biopharma Accelerates IP Momentum: Files Fourth Provisional Patent Application in Just Two Months – Strengthening Global Protection for Breakthrough Proenzyme Formulations

Indeterminate GlobeNewswire
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Jan. 27, 2026

Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program

Indeterminate GlobeNewswire
TRIMEDX named recipient of Modern Healthcare’s Best in Business Award in Cybersecurity category
Jan. 27, 2026

TRIMEDX named recipient of Modern Healthcare’s Best in Business Award in Cybersecurity category

Indeterminate GlobeNewswire
Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma
Jan. 27, 2026

Imviva Biotech Receives FDA Orphan Drug Designation for CTD402 for the Treatment of T-Cell Leukemia and Lymphoma

Indeterminate GlobeNewswire
SRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million
Jan. 27, 2026

SRx Health Solutions Allocates Further Capital to its Digital Asset Treasury Hedging Strategy, Bringing Total Allocation to $18 Million

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome
Jan. 27, 2026

Quoin Pharmaceuticals Announces Submission to Japanese MHLW for Orphan Drug Designation for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions